CorMedix Inc.

    Jurisdiction
    United States
    LEI
    5299006YIA3L0MBW8358
    ISIN
    US21900C3088 (CRMD)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 47 / 100
    Worse than peer group:
    49 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €104.66M
    Gross margin
    95.6%
    EBIT
    €42.49M
    EBIT margin
    40.6%
    Net income
    €44.08M
    Net margin
    42.1%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €353.98M +238.2% €174.61M +296.2%
    €351.18M -0.8% €176.88M +1.3%
    €404.82M +15.3% €200.19M +13.2%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: May 9, 2024

    Add to watchlist

    Notifications